A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Clinical trial NCT07107945 · RECRUITING
Trial details
- NCT number
- NCT07107945
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-09
- Primary completion
- 2027-04-16
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.